1. Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes. Issue 2 (7th December 2014) Authors: D'Alessio, D.; Häring, H.‐U.; Charbonnel, B.; de Pablos‐Velasco, P.; Candelas, C.; Dain, M.‐P.; Vincent, M.; Pilorget, V.; Yki‐Järvinen, H.; on behalf of the EAGLE Investigators Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 2(2015:Feb.) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes. Issue 1 (12th July 2014) Authors: Home, P. D.; Bolli, G. B.; Mathieu, C.; Deerochanawong, C.; Landgraf, W.; Candelas, C.; Pilorget, V.; Dain, M.‐P.; Riddle, M. C. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 1(2015:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary‐care observational database study of the efficacy of GLP‐1 receptor agonists and insulin in the UK. Issue 6 (19th May 2013) Authors: Hall, G. C.; McMahon, A. D.; Dain, M.‐P.; Wang, E.; Home, P. D. Journal: Diabetic medicine Issue: Volume 30:Issue 6(2013:Jun.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗